If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 152.50
Bid: 150.00
Ask: 155.00
Change: -5.00 (-3.17%)
Spread: 5.00 (3.333%)
Open: 157.50
High: 157.50
Low: 152.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Jul 2023 07:00

RNS Number : 7141F
Itaconix PLC
12 July 2023
 

For release: 07.00, 12 July 2023

 

Itaconix plc

("Itaconix" or the "Company")

Trading Update

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to provide a trading update for the half year to 30 June 2023.

The Company achieved its fifth consecutive year of record results for the first six months, with unaudited revenues of $4.0 million. These revenues represent 32% growth over the first half of 2022 and 58% growth over the second half of 2022. Additionally, they are 72% of the full year revenues for 2022 and 155% of the full year revenues for 2021.

Cleaning applications generated 92% of first half revenues, indicating a 33% increase compared to the first half of 2022, driven by continued gains in North American and European detergent volumes. The Company maintained strong volumes throughout the first six months and is entering the second half with a solid order book and expected volumes.

Hygiene and beauty applications delivered a 7% increase in revenues compared to the first half of 2022, and saw use of our ingredients in new FMCG product brands.

Overall gross profit margin for the first six months exceeded that of the full year for 2022 due to higher product volumes and more stable raw material costs.

Net unaudited cash as at 30 June 2023 was $11.2 million.

Further details on first half results will be provided in the 2023 interim report, which the Company plans to release in early September 2023.

Itaconix's ability to decarbonize everyday products stems from enabling an increase in the use of plant-based content and a conservation in the total amount of ingredients used. In the first half of 2023, Itaconix ingredients with more than 70% bio-based content accounted for 85% of revenues, while ingredients with 100% bio-based content represented 33%. Although Itaconix no longer qualifies for the LSE Green Economy Mark, the Company appreciates the LSE's promotion of the new low-carbon economy and recognizes the complexities of evolving decarbonization activities across diverse industries.

John R. Shaw, CEO of Itaconix, commented:

"Our record first half revenues place us in a strong position to meet market expectations for 2023. With increased commercial traction across our technology platform, we are building a recurring revenue base, experiencing consistent high revenue growth, and fostering a pipeline of new revenue opportunities to achieve our goal of becoming a large, profitable specialty ingredient company."

 

- Ends -

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 74 070 23147

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's products contribute to the global low carbon economy.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDRIDBDGXB
Date   Source Headline
20th Nov 20137:00 amRNSMarketing approval of nicotine gum in Europe
17th Oct 20137:00 amRNSSupply and Distribution Agreement with Amma Polska
11th Oct 20137:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Sep 20137:00 amRNSInterim Results
1st Aug 20137:00 amRNSTotal Voting Rights
22nd Jul 20137:00 amRNSAward of contract to supply nicotine gum
15th Jul 201312:20 pmRNSChange of Registered Office
9th Jul 20137:00 amRNSBlocklisting Interim Review
28th May 20132:02 pmRNSResult of AGM
17th Apr 20134:47 pmRNSHolding(s) in Company
17th Apr 20137:00 amRNSDirector's Dealings
9th Apr 20137:00 amRNSPositive test results for encapsulation technology
22nd Mar 20137:00 amRNSNotice of AGM and Posting of Annual Report
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 20137:00 amRNSTotal Voting Rights
1st Feb 20132:42 pmRNSNotice of patent infringement proceedings
10th Jan 20137:01 amRNSAwards under Long Term Incentive Plan
10th Jan 20137:00 amRNSBlock Listing
8th Jan 20131:59 pmRNSHolding(s) in Company
19th Dec 20122:14 pmRNSEstablishment of Employee Benefit Trust
19th Dec 20127:00 amRNSTrading Update
25th Sep 20127:00 amRNSInterim Results
13th Sep 20127:00 amRNSBoard Appointment
17th Aug 20127:00 amRNSIssue of Warrants
30th Jul 20127:00 amRNSCanadian Distribution Deals Won
10th Jul 20128:09 amRNSBoard Appointment
10th Jul 20128:05 amRNSAIM Admission - First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.